Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit
Romualdo Barroso‐Sousa(Sociedade Brasileira de Oncologia Clínica), Sara M. Tolaney(Harvard University), Tess A. O’Meara(Yale University), Edward T. Richardson(Brigham and Women's Hospital), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Patrick A. Ott(Dana-Farber Cancer Institute), Catherine J. Wu(Dana-Farber Cancer Institute), Zachary Weber(The Ohio State University), Nancy U. Lin(Dana-Farber Cancer Institute), Daniel G. Stover(Harvard University), Katharine A. Collier(The Ohio State University), Scott J. Rodig(Brigham and Women's Hospital), Deborah Dillon(Harvard University), Nikhil Wagle(Dana-Farber Cancer Institute), Eric P. Winer(University of Vermont), Michael P. Manos(Harvard University), Katrina Kao(Dana-Farber Cancer Institute), Tejas Jammihal(Children's Hospital of Philadelphia), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Ofir Cohen(Broad Institute), F. Stephen Hodi(Harvard University), Victoria Attaya(Harvard University), Ryan Brennick(Dana-Farber Cancer Institute), Tanya E. Keenan(Massachusetts General Hospital), Juliet Forman(Broad Institute), Elizabeth A. Mittendorf(Beth Israel Deaconess Medical Center)
Cited by 41
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
|Cell|2015|4.2k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k